Medicare has an impending value-based purchasing program for hospitals. Payments would be based on performance against quality standards. Some hospitals ability to improve performance may be limited by the economic…
Read More
Home infusion of therapeutic agents is increasing, especially as more biologics, which tend to need infusion, are approved for use. GAO looked at how Medicare FFS handles home infusion versus…
Read More
Medicare's Part D benefit covers most prescription drugs and has added significantly to the program's cost, although not as much as originally projected. Now that the program has been in…
Read More